Abiraterone Acetate Tablets Abitate 250mg

Get a Price/Quote

MOQ : 10 Pieces

Abiraterone Acetate Tablets Abitate 250mg Specification

Dosage Form
Tablet

Indication
Prostate Cancer

Salt Composition
Abiraterone Acetate

Feature
Prescription only, High purity, International export quality

Ingredients
Abiraterone Acetate, Excipients

Application
Oral Anti-Cancer Medication

Physical Color/Texture
Tablet form

Storage Instructions
Store below 30C, protect from moisture

Shelf Life
24 months from manufacturing

Route of Administration
Oral

Country of Export
Available for export to Canada, EU, UK, USA, Australia

Prescription Required
Yes

Strength
250 mg

Brand Name
Abitate

Packaging Type
Blister Pack, Box

Usage
For use under medical supervision only

Pack Size
120 Tablets per Pack (as standard)

Abiraterone Acetate Tablets Abitate 250mg About

Get Abiraterone Acetate Tablets Abitate 250mg-an affordable, first-class oral anti-cancer formulation for advanced prostate cancer management. Available in convenient blister pack boxes, each pack contains 120 laureate-quality tablets, ensuring reliable dosing. Procure this internationally trusted medication, manufactured and supplied from India with strict export standards for Canada, EU, UK, USA, and Australia. Each prescription-only tablet offers high purity and first-string efficacy, containing Abiraterone Acetate and select excipients. Recommended for medical use and supervision, Abitate upholds international quality benchmarks. Store below 30C, protected from moisture; shelf life is 24 months.

Specific Usage and Commercial Benefits

Abiraterone Acetate Tablets Abitate 250mg are specifically indicated for the oral treatment of advanced prostate cancer. Used under strict medical supervision, these tablets offer both therapeutic and commercial advantages for healthcare professionals. Designed for first-string use in clinical and hospital settings, Abitate is suitable for oncologists and medical suppliers seeking reliable and affordable cancer therapy options for prostate cancer patients.

Sample Policy and Export Readiness

With a transparent sample policy, Abitate 250mg tablets can be supplied as trial packs to qualified partners. Stock is ready and available, ensuring prompt fulfilment of orders. Abitate offers seamless export to main markets such as Canada, the EU, UK, USA, and Australia. This enables distributors and healthcare providers to confidently supply their clientele with a laureate-grade oncology medication backed by consistent stock and professional service.

FAQ's of Abiraterone Acetate Tablets Abitate 250mg:

Q: How should Abiraterone Acetate Tablets Abitate 250mg be taken?

A: Abitate should be taken orally, strictly under medical supervision, as prescribed by your healthcare provider, usually in combination with other therapies for prostate cancer.

Q: What makes Abitate 250mg a preferred choice for prostate cancer treatment?

A: Abitate 250mg is a first-string, internationally exported oral anti-cancer medication known for its high purity and affordable cost, making it a reliable option for both patients and commercial suppliers.

Q: When are sample packs of Abitate 250mg available for potential partners?

A: Sample packs can be supplied to qualified healthcare professionals or distributors based on request and compliance with the manufacturer's sample policy, subject to approval.

Q: Where can Abitate 250mg be exported?

A: Abitate 250mg is available for export to Canada, EU countries, the UK, USA, Australia, and select other international markets.

Q: What is the storage process for maintaining Abitate 250mg's quality?

A: Keep the tablets below 30C and protect them from moisture to ensure their shelf life of 24 months from the manufacturing date.

Q: What is the benefit of procuring Abitate 250mg from the manufacturer in India?

A: Procuring directly ensures access to a first-class, globally recognized product with stock ready, backed by international export standards and reliable quality assurance.

Tell us about your requirement